Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert I. Tepper currently holds 5,073,933 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert I. Tepper has been a net seller of GBT stock. They have purchased $7.0M and sold $280.9M worth of shares.
Robert I. Tepper's most recent insider trade was on Jan 27, 2023, when they sold 50,000 shares at $9.02 per share.
Robert I. Tepper serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 91 insider transactions totaling $287.9M over their tenure at the company.
Robert I. Tepper holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Robert I. Tepper has shown a selling trading pattern, with $7.0M in total purchases and $280.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert I. Tepper was on Jan 14, 2021, when they sold $80.6M worth of RLAY shares. This transaction involved 1,965,294 shares at $41.00 per share.
Robert I. Tepper currently owns 5,073,933 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert I. Tepper's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert I. Tepper has 91 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for Robert I. Tepper and 40,000+ other insiders.